ABCC7 p.Glu588Val
[switch to full view]Comments [show]
None has been submitted yet.
PMID: 17481968
[PubMed]
Storm K et al: "High incidence of the CFTR mutations 3272-26A-->G and L927P in Belgian cystic fibrosis patients, and identification of three new CFTR mutations (186-2A-->G, E588V, and 1671insTATCA)."
No.
Sentence
Comment
0
High incidence of the CFTR mutations 3272-26A→G and L927P in Belgian cystic fibrosis patients, and identification of three new CFTR mutations (186-2A→G, E588V, and 1671insTATCA) Katrien Storm a,⁎, Els Moens b , Lieve Vits a , Haike De Vlieger a , Gino Delaere a , Maria D'Hollander a , Wim Wuyts a , Martine Biervliet a , Lutgardis Van Schil c , Kristine Desager b , Markus M. Nöthen a,1 a Department of Medical Genetics, University and University Hospital of Antwerp, Antwerp, Belgium b Department of Pediatrics, University Hospital of Antwerp, Antwerp, Belgium c Department of Pneumonology, Sint-Vincentiusziekenhuis, Antwerp, Belgium Accepted 10 October 2006 Available online 3 May 2007 Abstract We have analyzed 143 unrelated Belgian patients with a positive diagnosis of cystic fibrosis (CF) for mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
X
ABCC7 p.Glu588Val 17481968:0:165
status: NEW3 In addition to 10 previously reported mutations we identified 2 new mutations 186-2A→G and E588V.
X
ABCC7 p.Glu588Val 17481968:3:97
status: NEW6 The clinical data is presented for the mutations 186-2A→G, E588V, 3272-26A→G and L927P.
X
ABCC7 p.Glu588Val 17481968:6:65
status: NEW54 From the 12 different mutations identified by DGGE 10 mutations are reported before and 2 mutations (186-2A→G and E588V) are new.
X
ABCC7 p.Glu588Val 17481968:54:120
status: NEW104 E588V.
X
ABCC7 p.Glu588Val 17481968:104:0
status: NEW105 The missense mutation E588Vis caused by a transversion of A to T at nucleotide 1895 in exon 12 of the CFTR gene leading to a change of glutamic acid to valine at amino acid position 588.
X
ABCC7 p.Glu588Val 17481968:105:0
status: NEWX
ABCC7 p.Glu588Val 17481968:105:135
status: NEW107 The patient is compound heterozygous for ΔF508 and E588V.
X
ABCC7 p.Glu588Val 17481968:107:57
status: NEW108 Arguments for a pathogenic character of E588V are (1) the mutation was not detected in 96 control chromosomes, (2) a relative large charged polar amino acid is substituted by a small apolar amino acid.
X
ABCC7 p.Glu588Val 17481968:108:40
status: NEWX
ABCC7 p.Glu588Val 17481968:108:56
status: NEW113 Twenty-five different mutations were identified including two new CFTR mutations 186-2A→G and E588V.
X
ABCC7 p.Glu588Val 17481968:113:101
status: NEW114 Two known mutations 3272-26A→G and L927P were shown to occur with a higher frequency in Antwerp compared to other Belgian regions.
X
ABCC7 p.Glu588Val 17481968:114:100
status: NEW106 The missense mutation E588Vis caused by a transversion of A to T at nucleotide 1895 in exon 12 of the CFTR gene leading to a change of glutamic acid to valine at amino acid position 588.
X
ABCC7 p.Glu588Val 17481968:106:135
status: NEW109 Arguments for a pathogenic character of E588V are (1) the mutation was not detected in 96 control chromosomes, (2) a relative large charged polar amino acid is substituted by a small apolar amino acid.
X
ABCC7 p.Glu588Val 17481968:109:40
status: NEW
PMID: 15858154
[PubMed]
Schrijver I et al: "Diagnostic testing by CFTR gene mutation analysis in a large group of Hispanics: novel mutations and assessment of a population-specific mutation spectrum."
No.
Sentence
Comment
78
Of these additional 82 mutations 15 were novel, but one of these occurred twice (E588V).
X
ABCC7 p.Glu588Val 15858154:78:81
status: NEW101 E588V A 5-month-old female of Northwestern European and Hispanic ancestry with a positive newborn screening by Table 2.
X
ABCC7 p.Glu588Val 15858154:101:0
status: NEW102 Novel Variants Detected in 257 Hispanic Patients Patient Novel variant 1 Other variants Age and symptoms 1 1429del7bp G542X Newborn with intestinal blockage 2 S573C None 9 years old, pancreatitis, limited clinical history 3 Y913X deltaF508/I1027T 1 month old, vomiting, weight loss, diarrhea 4 E588V deltaF508/R1438W Identified one time in a family, family studies revealed deltaF508 and R1438W are in cis 5 E588V G542X Newborn with pneumonia and sweat chloride of 59 mmol/L 6 P439S R668C 10 years old with mild CF symptoms; another patient with CBAVD has P439S/R334W 7 T604S deltaF508 1 month old 8 874insTACA deltaF508 Newborn with meconium ileus and IUGR 9 2585delT deltaF508/I1027T 13 years old with CF 10 1811 ϩ 1 G to A None 44 years old with positive sweat chloride; also seen in 5-year-old CF patient with 3821delT mutation 11 I285F None 1 year old with chronic respiratory problems, also carries a silent mutation at A455 12 P1372L None 1 month old, rule out CF 13 3271 ϩ 8 A to G None 16 years old, borderline sweat test 14 1341 ϩ 80 G to A None Recurrent sinusitis 15 1525 - 42 G to A None Two patients, one 9 years old with FTT, and one 18 months old with chronic lung disease, pulmonary hypotension, hypoxia CBAVD, congenital bilateral absence of the vas deference; IUGR, intrauterine growth retardation.
X
ABCC7 p.Glu588Val 15858154:102:294
status: NEWX
ABCC7 p.Glu588Val 15858154:102:408
status: NEW112 In the CF mutation database, this variant also occurred in combination with other sequence variants: S977F in cis, and ⌬F508 in trans.10 The E588V variant, which is in trans in our subject, is caused by an AϾT nucleotide substitution in position 1895 in exon 12.
X
ABCC7 p.Glu588Val 15858154:112:148
status: NEW187 CFTR Sequence Variants Identified in Five Comprehensive CFTR Studies in US Hispanics CFTR mutations Alleles Relative mutation frequency (%) (of 317) deltaF508 123 38.80 3876delA 15 4.70 G542X 12 3.80 406 - 1GϾA 8 2.50 3849 ϩ 10kbCϾT 5 1.60 R75X 4 1.30 935delA 4 1.30 S549N 4 1.30 W1204X 4 1.30 R334W 4 1.30 2055del9ϾA 3 1 R74W 3 1 H199Y 3 1 L206W 3 1 663delT 3 1 3120 ϩ 1GϾA 3 1 L997F 3 1 I1027T 3 1 R1066C 3 1 W1089X 3 1 D1270N 3 1 2105del13insAGAAA 3 1 Q98R 2 Ͻ1 E116K 2 Ͻ1 I148T 2 Ͻ1 R668C 2 Ͻ1 P205S 2 Ͻ1 V232D 2 Ͻ1 S492F 2 Ͻ1 T501A 2 Ͻ1 1949del84 2 Ͻ1 Q890X 2 Ͻ1 3271delGG 2 Ͻ1 3272 - 26AϾG 2 Ͻ1 G1244E 2 Ͻ1 D1445N 2 Ͻ1 R553X 2 Ͻ1 E588V 2 Ͻ1 1717 - 8GϾA 2 Ͻ1 A1009T 2 Ͻ1 S1235R 2 Ͻ1 G85E 1 Ͻ1 296 ϩ 28AϾG 1 Ͻ1 406 - 6TϾC 1 Ͻ1 V11I 1 Ͻ1 Q179K 1 Ͻ1 V201 mol/L 1 Ͻ1 874insTACA 1 Ͻ1 I285F 1 Ͻ1 deltaF311 1 Ͻ1 F311L 1 Ͻ1 L320V 1 Ͻ1 T351S 1 Ͻ1 R352W 1 Ͻ1 1248 ϩ 1GϾA 1 Ͻ1 1249 - 29delAT 1 Ͻ1 1288insTA 1 Ͻ1 1341 ϩ 80GϾA 1 Ͻ1 1429del7 1 Ͻ1 1525 - 42GϾA 1 Ͻ1 P439S 1 Ͻ1 1717 - 1GϾA 1 Ͻ1 1811 ϩ 1GϾA 1 Ͻ1 deltaI507 1 Ͻ1 G551D 1 Ͻ1 A559T 1 Ͻ1 Y563N 1 Ͻ1 (Table continues) In this study, we used temporal temperature gradient gel electrophoresis (TTGE) and direct DNA sequencing to increase the sensitivity of mutation detection in U.S. Hispanics, and to determine whether additional mutations are recurrent.
X
ABCC7 p.Glu588Val 15858154:187:768
status: NEW201 Comparison of Relative Frequencies of CFTR Sequence Variants in Comprehensive CFTR Studies in US and Mexican Hispanics This study % Orozco 2000 % US/ Mexican % deltaF508 28.96 54.48 43.72 G542X 3.83 8.28 5.19 406 - 1GϾA 3.28 2.07 2.38 W1204X 2.19 Ͻ1 1.08 R74W 1.64 Ͻ1 R75X 1.64 2.07 1.51 H199Y 1.64 Ͻ1 Ͻ1 L206W 1.64 Ͻ1 L997F 1.64 Ͻ1 I1027T 1.64 Ͻ1 2055del9ϾA 1.64 1.38 1.27 D1270N 1.64 Ͻ1 E116K 1.09 Ͻ1 V232D 1.09 Ͻ1 R334W 1.09 Ͻ1 S492F 1.09 Ͻ1 T501A 1.09 Ͻ1 R553X 1.09 Ͻ1 Ͻ1 E588V 1.09 Ͻ1 R668C 1.09 Ͻ1 Q890X 1.09 Ͻ1 W1089X 1.09 Ͻ1 S1235R 1.09 Ͻ1 D1445N 1.09 Ͻ1 3876delA 1.09 3.24 1717 - 8GϾA 1.09 Ͻ1 3272 - 26AϾG 1.09 Ͻ1 A1009T 1.09 Ͻ1 deltaI507 Ͻ1 3.45 1.30 S549N Ͻ1 3.45 1.95 G567A Ͻ1 Ͻ1 I148T 2.07 1.08 I506T 1.38 Ͻ1 N1303K 2.76 1.08 935delA 1.38 1.30 2183AAϾG 1.38 Ͻ1 3199del6 1.38 Ͻ1 3849 ϩ 10kbCϾT Ͻ1 1.30 ACMG/ACOG italicized.
X
ABCC7 p.Glu588Val 15858154:201:578
status: NEW
PMID: 10069375
[PubMed]
Tasch JE et al: "Functional dissection of the R domain of cystic fibrosis transmembrane conductance regulator."
No.
Sentence
Comment
27
De'nition and in vitro expression of R domain sub-domains The R domain (from glutamate 588 to valine 855) was divided into three separate sub-domains (Fig. 1).
X
ABCC7 p.Glu588Val 10069375:27:77
status: NEW